Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Feb 29, 2016
SEATTLE, Feb. 29, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the fourth quarter and year ended December 31, 2015. Fourth Quarter Financial HighlightsTotal revenue of $22.3 million, 43% y...
Feb 29, 2016
SEATTLE, Feb. 29, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a collaboration agreement with Merck, known as MSD outside the US and Canada, through a subsidiary, to develop and commercia...
Feb 22, 2016
SEATTLE, Feb. 22, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company's management is scheduled to present at the Cowen and Company 36th Annual Health Care Conference in Boston. Brad Gray, Presiden...
Feb 12, 2016
SEATTLE, Feb. 12, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release fourth quarter 2015 financial results after the close of trading on Monday, February 29, 2016. Company management will ...
Feb 11, 2016
ORLANDO, Fla., Feb. 11, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today presented the first proof-of-concept data for its novel massively parallel single molecule sequencing chemistry, Hyb & SeqTM, at the Advances in Genome B...
Feb 9, 2016
SEATTLE, Feb. 09, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the updated American Society of Clinical Oncology (ASCO) Clinical Practice Guideline on the appropriate use of breast tumor biomarker assay resu...
Jan 27, 2016
SEATTLE, Jan. 27, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company's management is scheduled to present at the Leerink Partners 5th Annual Global Healthcare Conference in New York City. Brad Gra...
Jan 10, 2016
SEATTLE, Jan. 10, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided preliminary operational and financial results for the year ended December 31, 2015. Financial Highlights: Total revenue for 2015 expected to be ...
Jan 7, 2016
SAN FRANCISCO, CA and SEATTLE, WA--(Marketwired - Jan 7, 2016) - Medivation, Inc. (NASDAQ: MDVN) and NanoString Technologies, Inc., (NASDAQ: NSTG) today announced they have entered into a collaboration, together with Astellas Pharma Inc., to pursue the translation of a novel gen...
Dec 23, 2015
SEATTLE, Dec. 23, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company's management is scheduled to present at the J.P. Morgan 34th Annual Healthcare Conference in San Francisco. Brad Gray, Presid...
Dec 7, 2015
SEATTLE, Dec. 7, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that eleven posters for the Prosigna® Breast Cancer Gene Signature Assay and the PAM50 gene signature, the basis for Prosigna, will be presented at...
Nov 5, 2015
SEATTLE, Nov. 5, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company's management is scheduled to present at the Canaccord Genuity Medical Technology and Diagnostics Forum in New York City. Brad G...
Nov 5, 2015
SEATTLE, Nov. 5, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the expansion of its 3D Biology™ portfolio with the commercial launch of the nCounter® PanCancer Profiles, seven new gene expression panels e...
Nov 2, 2015
Record Revenue of $15.7 Million Driven by Strong Consumables Demand Expanded Solutions in Precision Oncology, including nCounter SPRINT and 3D Biology, Strengthen Company's Position at Center of Cancer Ecosystem SEATTLE, Nov. 2, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools f...
Oct 12, 2015
SEATTLE, Oct. 12, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release third quarter 2015 financial results after the close of trading on Monday, November 2, 2015. Company management will host...
Page: First Previous
...
...
Next Last
 
= add release to Briefcase